YUNREZU Trademark

Trademark Overview


On Wednesday, February 19, 2020, a trademark application was filed for YUNREZU with the United States Patent and Trademark Office. The USPTO has given the YUNREZU trademark a serial number of 79281430. The federal status of this trademark filing is REGISTERED as of Tuesday, September 8, 2020. This trademark is owned by Glaxo Group Limited. The YUNREZU trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines
yunrezu

General Information


Serial Number79281430
Word MarkYUNREZU
Filing DateWednesday, February 19, 2020
Status700 - REGISTERED
Status DateTuesday, September 8, 2020
Registration Number6144441
Registration DateTuesday, September 8, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 23, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 24, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Monday, July 31, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, November 21, 2020NOTIFICATION PROCESSED BY IB
Monday, November 2, 2020FINAL DISPOSITION NOTICE SENT TO IB
Monday, November 2, 2020FINAL DISPOSITION PROCESSED
Thursday, October 8, 2020GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, September 8, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, June 23, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 3, 2020NOTICE OF PUBLICATION
Friday, May 15, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 7, 2020ASSIGNED TO EXAMINER
Saturday, March 28, 2020APPLICATION FILING RECEIPT MAILED
Tuesday, March 24, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 23, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, March 19, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB